Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Araoka H"" wg kryterium: Autor


Tytuł:
High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults.
Autorzy:
Takagi S; Department of Haematology, Toranomon Hospital, Tokyo, Japan.
Masuoka K
Uchida N
Ishiwata K
Araoka H
Tsuji M
Yamamoto H
Kato D
Matsuhashi Y
Kusumi E
Ota Y
Seo S
Matsumura T
Matsuno N
Wake A
Miyakoshi S
Makino S
Ohashi K
Yoneyama A
Taniguchi S
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2009 Nov; Vol. 147 (4), pp. 543-53. Date of Electronic Publication: 2009 Aug 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cord Blood Stem Cell Transplantation/*adverse effects
Hematologic Neoplasms/*therapy
Lymphohistiocytosis, Hemophagocytic/*etiology
Adolescent ; Adult ; Aged ; Antigens, CD34/analysis ; Cord Blood Stem Cell Transplantation/methods ; Female ; Graft Rejection ; Graft vs Host Disease/prevention & control ; Humans ; Male ; Middle Aged ; Risk Factors ; Survival Analysis ; Transplantation Chimera ; Transplantation Conditioning/methods ; Young Adult
Czasopismo naukowe
Tytuł:
Infective endocarditis complicated with splenic abscess successfully treated with splenectomy followed by double valve replacement.
Autorzy:
Naito R; Cardiovascular Center, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.
Mitani H; Cardiovascular Center, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.
Ishiwata S; Cardiovascular Center, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.
Yamaguchi T; Cardiovascular Center, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.
Tanaka K; Cardiovascular Center, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.
Naruse Y; Cardiovascular Center, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.
Araoka H; Department of Infectious Disease, Toranomon Hospital, Tokyo, Japan.
Hashimoto M; Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.
Ohno M; Cardiovascular Center, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan.
Pokaż więcej
Źródło:
Journal of cardiology cases [J Cardiol Cases] 2010 Mar 30; Vol. 2 (1), pp. e20-e22. Date of Electronic Publication: 2010 Mar 30 (Print Publication: 2010).
Typ publikacji:
Case Reports
Raport
Tytuł:
Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009.
Autorzy:
Araoka H; Department of Infectious Diseases, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan. h-araoka@toranomon.gr.jp
Baba M
Yoneyama A
Pokaż więcej
Źródło:
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2010 May; Vol. 29 (5), pp. 605-8. Date of Electronic Publication: 2010 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Bacteremia/*mortality
Gram-Negative Bacterial Infections/*mortality
Stenotrophomonas maltophilia/*isolation & purification
Adult ; Aged ; Aged, 80 and over ; Analysis of Variance ; Bacteremia/epidemiology ; Bacteremia/microbiology ; Chi-Square Distribution ; Female ; Gram-Negative Bacterial Infections/epidemiology ; Gram-Negative Bacterial Infections/microbiology ; Humans ; Japan/epidemiology ; Male ; Middle Aged ; Risk Factors ; Statistics, Nonparametric
Czasopismo naukowe
Tytuł:
Aeromonas caviae is the most frequent pathogen amongst cases of Aeromonas bacteremia in Japan.
Autorzy:
Kimura M; Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
Araoka H
Yoneyama A
Pokaż więcej
Źródło:
Scandinavian journal of infectious diseases [Scand J Infect Dis] 2013 Apr; Vol. 45 (4), pp. 304-9. Date of Electronic Publication: 2012 Nov 20.
Typ publikacji:
Journal Article
MeSH Terms:
Aeromonas caviae/*isolation & purification
Bacteremia/*microbiology
Gram-Negative Bacterial Infections/*microbiology
Adult ; Aged ; Aged, 80 and over ; Bacteremia/epidemiology ; Drug Resistance, Bacterial ; Female ; Gram-Negative Bacterial Infections/epidemiology ; Humans ; Japan/epidemiology ; Male ; Microbial Sensitivity Tests ; Middle Aged ; Neoplasms/complications ; Retrospective Studies ; Seasons ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Analysis of the influence of drug resistance factors on the efficacy of combinations of antibiotics for multidrug-resistant Pseudomonas aeruginosa isolated from hospitals located in the suburbs of Kanto area, Japan.
Autorzy:
Kataoka H; Pharmaceutical Research Center, Meiji Seika Pharma Co., Ltd., Tokyo 104 8002, Japan.
Ida T; Pharmaceutical Research Center, Meiji Seika Pharma Co., Ltd., Tokyo 104 8002, Japan.
Ishii Y; Department of Microbiology and Infectious Diseases, Faculty of Medicine, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, Tokyo 143 8540, Japan. Electronic address: .
Tateda K; Department of Microbiology and Infectious Diseases, Faculty of Medicine, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, Tokyo 143 8540, Japan.
Oguri T; Kameda General Hospital, Chiba 296-8602, Japan.
Yoshida A; Dokkyo Medical University Hospital, Tochigi 321 0293, Japan.
Okuzumi K; Dokkyo Medical University Hospital, Tochigi 321 0293, Japan.
Oishi T; Tokyo Medical University Ibaraki Medical Center, Ibaraki 300 0395, Japan.
Tsukahara M; Tokyo Medical University Ibaraki Medical Center, Ibaraki 300 0395, Japan.
Mori SI; National Cancer Center Hospital, Tokyo 104 0045, Japan.
Yoneyama A; Department of Infectious Diseases, Toranomon Hospital, Tokyo 105 8470, Japan.
Araoka H; Department of Infectious Diseases, Toranomon Hospital, Tokyo 105 8470, Japan.
Mitsuda T; Yokohama City University Hospital, Kanagawa 236 0004, Japan.
Sumitomo M; Yokohama City University Hospital, Kanagawa 236 0004, Japan.
Moriya K; Graduate School of Medicine, The University of Tokyo, Tokyo 113 8655, Japan.
Goto M; Graduate School of Medicine, The University of Tokyo, Tokyo 113 8655, Japan.
Nakamori Y; Department of Respiratory Diseases, Misyuku Hospital, Tokyo 153 051, Japan.
Shibayama A; Department of Respiratory Diseases, Misyuku Hospital, Tokyo 153 051, Japan.
Ohmagari N; Shizuoka Cancer Center, Shizuoka 411 8777, Japan.
Sato T; Shizuoka Cancer Center, Shizuoka 411 8777, Japan.
Yamaguchi K; Department of Microbiology and Infectious Diseases, Faculty of Medicine, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, Tokyo 143 8540, Japan.
Pokaż więcej
Corporate Authors:
ABX Combination Therapy Study Group (ACTs)
Źródło:
Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2013 Jun; Vol. 1 (2), pp. 91-96. Date of Electronic Publication: 2013 Apr 23.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning.
Autorzy:
Takagi S; Department of Hematology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-0001, Japan, .
Araoka H
Uchida N
Uchida Y
Kaji D
Ota H
Nishida A
Ishiwata K
Tsuji M
Yamamoto H
Ito T
Matsuno N
Yamamoto G
Asano-Mori Y
Hayashi M
Izutsu K
Masuoka K
Wake A
Makino S
Yoneyama A
Taniguchi S
Pokaż więcej
Źródło:
International journal of hematology [Int J Hematol] 2014; Vol. 99 (5), pp. 652-8. Date of Electronic Publication: 2014 Mar 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Premedication*
Antifungal Agents/*therapeutic use
Cord Blood Stem Cell Transplantation/*adverse effects
Mycoses/*etiology
Mycoses/*prevention & control
Transplantation Conditioning/*adverse effects
Voriconazole/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Antifungal Agents/adverse effects ; Antifungal Agents/pharmacokinetics ; Drug Interactions ; Female ; Graft Survival ; Graft vs Host Disease/drug therapy ; Graft vs Host Disease/etiology ; Hematologic Diseases/complications ; Hematologic Diseases/therapy ; Humans ; Immunosuppressive Agents/therapeutic use ; Male ; Middle Aged ; Mycoses/diagnosis ; Prospective Studies ; Risk Factors ; Vidarabine/administration & dosage ; Vidarabine/analogs & derivatives ; Voriconazole/adverse effects ; Voriconazole/pharmacokinetics ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies